The Venture Codex Logo

The Venture Codex

Rohto Pharmaceutical

1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, 544-8666, Japan

Overview

Pharmaceutical and cosmetics manufacturer with diverse health products.

Founded

1899

Deals ยท 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

Israel
Japan

Sector focus

Consumer Goods
Manufacturing
Pharmaceutical

Investment portfolio

3rounds
NAMEDATESIZE
Fast Beauty
Nov 2025Participated
$11 MSeries B
Baibys
Aug 2024Participated
$5 MSeries A
InnoJin
Mar 2024Led
$3 MSeries B
Fast Beauty
Nov 2025Participated
$11 MSeries B
Baibys
Aug 2024Participated
$5 MSeries A
InnoJin
Mar 2024Led
$3 MSeries B
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Rohto Pharmaceutical: 3 funding rounds are recorded in the selected participation categories.All available history.
Rohto Pharmaceutical: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B11

Monthly Deal Activity

Rohto Pharmaceutical: 3 deals are recorded across 32 months.All available history.
Rohto Pharmaceutical: 3 deals are recorded across 32 months. All available history
MonthDeals
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Rohto Pharmaceutical: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Rohto Pharmaceutical: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2
Hardware & Robotics1
Education & Workforce1
Enterprise Software1
Manufacturing1
AI & Machine Learning1
Professional Services1
Consumer & Lifestyle1

Deal Size Distribution

Rohto Pharmaceutical: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Rohto Pharmaceutical: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Rohto Pharmaceutical: Japan has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Rohto Pharmaceutical: Japan has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Japan2
Israel1
Rohto Pharmaceutical: 2 co-investors are shown, with Firstime Ventures sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Rohto Pharmaceutical: 2 co-investors are shown, with Firstime Ventures sharing 1 recorded deals. All available history
Co-investorShared deals
Firstime Ventures1
NVenture Capital1

Investment Strategy

Rohto Pharmaceutical: Led accounts for 33% and participating for 67% of round participation.All available history.
Rohto Pharmaceutical: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
Rohto Pharmaceutical: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Rohto Pharmaceutical: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

No team members found for this fund.